ELTX logo

ELTX
Elicio Therapeutics Inc

477
Mkt Cap
$201.08M
Volume
92,773.00
52W High
$14.93
52W Low
$4.85
PE Ratio
-4.20
ELTX Fundamentals
Price
$10.75
Prev Close
$10.62
Open
$10.60
50D MA
$11.31
Beta
0.72
Avg. Volume
124,115.86
EPS (Annual)
-$2.58
P/B
116.96
Rev/Employee
$0.00
$117.84
Loading...
Loading...
News
all
press releases
Elicio Therapeutics (NASDAQ:ELTX) Earns Buy Rating from Analysts at LADENBURG THALM/SH SH
LADENBURG THALM/SH SH assumed coverage on Elicio Therapeutics in a research report on Wednesday. They set a "buy" rating and a $20.00 price target for the company...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
Elicio Therapeutics (NASDAQ:ELTX) Trading 1.6% Higher - Here's What Happened
Elicio Therapeutics (NASDAQ:ELTX) Trading 1.6% Higher - Should You Buy...
MarketBeat·23d ago
News Placeholder
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
Wall Street Analysts Predict a 42.28% Upside in Elicio Therapeutics (ELTX): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 42.3% in Elicio Therapeutics (ELTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·2mo ago
News Placeholder
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Here is how Quest Diagnostics (DGX) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
Zacks·4mo ago
News Placeholder
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
Elicio Therapeutics (ELTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·5mo ago
<
...
1
>

Latest ELTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.